Scenario analyses
| Treatment . | Costs . | Life-years . | QALYs . | Incremental . | ICER per QALY . | |
|---|---|---|---|---|---|---|
| Costs . | QALY . | |||||
| 5-y time horizon | ||||||
| Health care sector perspective | ||||||
| Liso-cel | $587 874 | 2.91 | 2.29 | $133 249 | 0.97 | $136 757 |
| SC | $454 625 | 1.97 | 1.31 | |||
| Societal perspective | ||||||
| Liso-cel | $702 280 | 2.91 | 2.29 | $81 918 | 0.97 | $84 075 |
| SC | $620 361 | 1.97 | 1.31 | |||
| Alternative utilities for R/R DLBCL | ||||||
| Health care sector perspective | ||||||
| Liso-cel | $668 624 | 5.34 | 2.70 | $201 001 | 1.46 | $137 856 |
| SC | $467 624 | 2.47 | 1.24 | |||
| Societal perspective | ||||||
| Liso-cel | $882 475 | 5.34 | 2.70 | $137 560 | 1.46 | $94 346 |
| SC | $744 914 | 2.47 | 1.24 | |||
| Long-term DLBCL survival at 5 y | ||||||
| Health care sector perspective | ||||||
| Liso-cel | $666 431 | 5.34 | 3.64 | $199 147 | 2.02 | $98 661 |
| SC | $467 285 | 2.47 | 1.62 | |||
| Societal perspective | ||||||
| Liso-cel | $880 282 | 5.34 | 3.64 | $135 706 | 2.02 | $67 232 |
| SC | $744 575 | 2.47 | 1.62 | |||
| 2023 Liso-cel list price | ||||||
| Health care sector perspective | ||||||
| Liso-cel | $704 347 | 5.34 | 3.64 | $217 651 | 2.02 | $107 926 |
| SC | $486 696 | 2.47 | 1.62 | |||
| Societal perspective | ||||||
| Liso-cel | $918 198 | 5.34 | 3.64 | $154 211 | 2.02 | $76 468 |
| SC | $763 987 | 2.47 | 1.62 | |||
| Treatment . | Costs . | Life-years . | QALYs . | Incremental . | ICER per QALY . | |
|---|---|---|---|---|---|---|
| Costs . | QALY . | |||||
| 5-y time horizon | ||||||
| Health care sector perspective | ||||||
| Liso-cel | $587 874 | 2.91 | 2.29 | $133 249 | 0.97 | $136 757 |
| SC | $454 625 | 1.97 | 1.31 | |||
| Societal perspective | ||||||
| Liso-cel | $702 280 | 2.91 | 2.29 | $81 918 | 0.97 | $84 075 |
| SC | $620 361 | 1.97 | 1.31 | |||
| Alternative utilities for R/R DLBCL | ||||||
| Health care sector perspective | ||||||
| Liso-cel | $668 624 | 5.34 | 2.70 | $201 001 | 1.46 | $137 856 |
| SC | $467 624 | 2.47 | 1.24 | |||
| Societal perspective | ||||||
| Liso-cel | $882 475 | 5.34 | 2.70 | $137 560 | 1.46 | $94 346 |
| SC | $744 914 | 2.47 | 1.24 | |||
| Long-term DLBCL survival at 5 y | ||||||
| Health care sector perspective | ||||||
| Liso-cel | $666 431 | 5.34 | 3.64 | $199 147 | 2.02 | $98 661 |
| SC | $467 285 | 2.47 | 1.62 | |||
| Societal perspective | ||||||
| Liso-cel | $880 282 | 5.34 | 3.64 | $135 706 | 2.02 | $67 232 |
| SC | $744 575 | 2.47 | 1.62 | |||
| 2023 Liso-cel list price | ||||||
| Health care sector perspective | ||||||
| Liso-cel | $704 347 | 5.34 | 3.64 | $217 651 | 2.02 | $107 926 |
| SC | $486 696 | 2.47 | 1.62 | |||
| Societal perspective | ||||||
| Liso-cel | $918 198 | 5.34 | 3.64 | $154 211 | 2.02 | $76 468 |
| SC | $763 987 | 2.47 | 1.62 | |||
All costs were adjusted to 2022 USD; values in the table are rounded, which may result in minor discrepancies in summation.